BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38072417)

  • 21. Mechanisms of Pinometostat (EPZ-5676) Treatment-Emergent Resistance in
    Campbell CT; Haladyna JN; Drubin DA; Thomson TM; Maria MJ; Yamauchi T; Waters NJ; Olhava EJ; Pollock RM; Smith JJ; Copeland RA; Blakemore SJ; Bernt KM; Daigle SR
    Mol Cancer Ther; 2017 Aug; 16(8):1669-1679. PubMed ID: 28428443
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Regulatory effect of resveratrol and prednisolone on MDR1 gene expression in acute lymphoblastic leukemia cell line (CCRF-CEM): An epigenetic perspective.
    Zadi Heydarabad M; Nikasa M; Vatanmakanian M; Azimi A; Farshdousti Hagh M
    J Cell Biochem; 2018 Jun; 119(6):4890-4896. PubMed ID: 29377275
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytosine arabinoside potentiates the apoptotic effect of bendamustine on several B- and T-cell leukemia/lymphoma cells and cell lines.
    Castegnaro S; Visco C; Chieregato K; Bernardi M; Albiero E; Zanon C; Madeo D; Rodeghiero F
    Leuk Lymphoma; 2012 Nov; 53(11):2262-8. PubMed ID: 22530665
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [PLK1 Expression in Mantle Cell Lymphoma and Its Clinical Significance].
    Shen LY; Lin CM
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Jun; 27(3):833-838. PubMed ID: 31204940
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bcl-2 degradation is an additional pro-apoptotic effect of polo-like kinase inhibition in cholangiocarcinoma cells.
    Sydor S; Jafoui S; Wingerter L; Swoboda S; Mertens JC; Gerken G; Canbay A; Paul A; Fingas CD
    World J Gastroenterol; 2017 Jun; 23(22):4007-4015. PubMed ID: 28652654
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The expression of PLK-1 in cervical carcinoma: a possible target for enhancing chemosensitivity.
    Zhang Y; Liu Y; Yang YX; Xia JH; Zhang HX; Li HB; Yu CZ
    J Exp Clin Cancer Res; 2009 Sep; 28(1):130. PubMed ID: 19775446
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibiting Polo-like kinase 1 causes growth reduction and apoptosis in pediatric acute lymphoblastic leukemia cells.
    Hartsink-Segers SA; Exalto C; Allen M; Williamson D; Clifford SC; Horstmann M; Caron HN; Pieters R; Den Boer ML
    Haematologica; 2013 Oct; 98(10):1539-46. PubMed ID: 23753023
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of 5' CpG demethylation and altered chromatin structure in the promoter region with transcriptional activation of the multidrug resistance 1 gene in human cancer cells.
    Kusaba H; Nakayama M; Harada T; Nomoto M; Kohno K; Kuwano M; Wada M
    Eur J Biochem; 1999 Jun; 262(3):924-32. PubMed ID: 10411657
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 5-Aza-2'-deoxycytidine induces p21WAF expression by demethylation of p73 leading to p53-independent apoptosis in myeloid leukemia.
    Schmelz K; Wagner M; Dörken B; Tamm I
    Int J Cancer; 2005 May; 114(5):683-95. PubMed ID: 15609309
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trypanosoma brucei Polo-like kinase is essential for basal body duplication, kDNA segregation and cytokinesis.
    Hammarton TC; Kramer S; Tetley L; Boshart M; Mottram JC
    Mol Microbiol; 2007 Sep; 65(5):1229-48. PubMed ID: 17662039
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chemotherapeutic drug-induced ABCG2 promoter demethylation as a novel mechanism of acquired multidrug resistance.
    Bram EE; Stark M; Raz S; Assaraf YG
    Neoplasia; 2009 Dec; 11(12):1359-70. PubMed ID: 20019844
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Altered DNA methylation is associated with docetaxel resistance in human breast cancer cells.
    Kastl L; Brown I; Schofield AC
    Int J Oncol; 2010 May; 36(5):1235-41. PubMed ID: 20372798
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hypermethylation of ATP-binding cassette B1 (ABCB1) multidrug resistance 1 (MDR1) is associated with cisplatin resistance in the A549 lung adenocarcinoma cell line.
    Li A; Song J; Lai Q; Liu B; Wang H; Xu Y; Feng X; Sun X; Du Z
    Int J Exp Pathol; 2016 Dec; 97(6):412-421. PubMed ID: 27995666
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeted Polo-like Kinase Inhibition Combined With Aurora Kinase Inhibition in Pediatric Acute Leukemia Cells.
    Jayanthan A; Hofmann B; Meier-Stephenson V; Perinpanayagam M; Dunn SE; Boklan J; Trippett TM; Truong TH; Narendran A
    J Pediatr Hematol Oncol; 2019 Aug; 41(6):e359-e370. PubMed ID: 30702467
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Polo-like kinase in trypanosomes: an odd member out of the Polo family.
    Kurasawa Y; An T; Li Z
    Open Biol; 2020 Oct; 10(10):200189. PubMed ID: 33050792
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Messenger RNA levels of the Polo-like kinase gene (PLK) correlate with cytokinesis in the Trypanosoma rangeli cell cycle.
    Prestes EB; Stoco PH; de Moraes MH; Moura H; Grisard EC
    Exp Parasitol; 2019 Sep; 204():107727. PubMed ID: 31344389
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Occurrence of Aurora A positive multipolar mitoses in distinct molecular classes of colorectal carcinomas and effect of Aurora A inhibition.
    Herz C; Schlürmann F; Batarello D; Fichter CD; Schöpflin A; Münch C; Hauschke D; Werner M; Lassmann S
    Mol Carcinog; 2012 Sep; 51(9):696-710. PubMed ID: 21739483
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of AKT3 expression on MYC- and caspase-8-dependent apoptosis caused by polo-like kinase inhibitors in HCT 116 cells.
    Nonomiya Y; Noguchi K; Tanaka N; Kasagaki T; Katayama K; Sugimoto Y
    Cancer Sci; 2016 Dec; 107(12):1877-1887. PubMed ID: 27699933
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Altered expression of topoisomerase IIalpha contributes to cross-resistant to etoposide K562/MX2 cell line by aberrant methylation.
    Asano T; Nakamura K; Fujii H; Horichi N; Ohmori T; Hasegawa K; Isoe T; Adachi M; Otake N; Fukunaga Y
    Br J Cancer; 2005 Apr; 92(8):1486-92. PubMed ID: 15798770
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Ricolinostat, a selective HDAC6 inhibitor, shows anti-lymphoma cell activity alone and in combination with bendamustine.
    Cosenza M; Civallero M; Marcheselli L; Sacchi S; Pozzi S
    Apoptosis; 2017 Jun; 22(6):827-840. PubMed ID: 28315173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.